Bath & Body Works Gears Up For Q3 Print; Here Are The Recent Forecast Changes From Wall Street's Most Accurate Analysts
Bath & Body Works Gears Up For Q3 Print; Here Are The Recent Forecast Changes From Wall Street's Most Accurate Analysts
Bath & Body Works shares gained 0.8% to close at $30.75 on Thursday.Bath & Body Works, Inc. (NYSE:BBWI) will release earnings results for the third quarter, before the opening bell on Monday, Nov. 25.
巴斯與身體工坊公司（紐交所：BBWI）將於11月25日星期一開盤前發佈第三季度的業績。
Analysts expect Bath & Body Works to report quarterly earnings at 47 cents per share. That's down from 48 cents per share a year ago. The Columbus, Ohio-based company projects to report quarterly revenue of $1.58 billion, compared to $1.56 billion a year earlier, according to data from Benzinga Pro.
分析師預計巴斯與身體工坊的季度每股收益爲47美分，低於去年的48美分。這家位於俄亥俄州哥倫布的公司預計季度營業收入爲15.8億美元，而去年爲15.6億美元，根據Benzinga Pro的數據。
On Nov. 8, Bath & Body Works announced the declaration of its regular quarterly dividend of 20 cents per share payable on Dec. 6, to shareholders of record at the close of business on Nov. 22.
11月8日，巴斯與身體工坊宣佈將於12月6日向11月22日收盤時登記者支付每股20美分的常規季度股息。
Bath & Body Works shares gained 0.8% to close at $30.75 on Thursday.
巴斯與身體工坊的股票在星期四上漲了0.8%，收盤價爲30.75美元。
Benzinga readers can access the latest analyst ratings on the Analyst Stock Ratings page. Readers can sort by stock ticker, company name, analyst firm, rating change or other variables.
Benzinga讀者可以在分析師股票評級頁面上查看最新的分析師評級。讀者可以按股票代碼、公司名稱、分析機構、評級變動或其他變量進行排序。
Let's have a look at how Benzinga's most-accurate analysts have rated the company in the recent period.
讓我們來看看Benzinga最準確的分析師們是如何在最近一段時間內評價這家公司的。
- Wells Fargo analyst Ike Boruchow maintained an Equal-Weight rating and cut the price target from $35 to $32 on Nov. 6. This analyst has an accuracy rate of 66%.
- BMO Capital analyst Simon Siegel reiterated an Outperform rating and lowered the price target from $52 to $50 on Aug. 29. This analyst has an accuracy rate of 75%.
- Goldman Sachs analyst Kate McShane maintained a Buy rating and cut the price target from $60 to $49 on Aug. 29. This analyst has an accuracy rate of 69%.
- JP Morgan analyst Matthew Boss maintained a Neutral rating and slashed the price target from $42 to $39 on Aug. 29. This analyst has an accuracy rate of 67%.
- Raymond James analyst Olivia Tong maintained a Neutral rating and cut the price target from $51 to $42 on Aug. 29. This analyst has an accuracy rate of 66%.
- 富國銀行分析師艾克·博魯喬夫維持中立評級，並於11月6日將目標價從35美元下調至32美元。該分析師的準確率爲66%。
- BMO資本分析師西蒙·西格爾重申了跑贏大盤的評級，並於8月29日將目標價從52美元下調至50美元。該分析師的準確率爲75%。
- 高盛分析師凱特·麥克謝恩在8月29日維持了買入評級，並將目標價從60美元下調至49美元。該分析師的準確率爲69%。
- 摩根大通分析師馬修·博斯在8月29日維持了中立評級，並將目標價從42美元下調至39美元。該分析師的準確率爲67%。
- 雷蒙德·詹姆斯分析師奧利維亞·湯在8月29日維持了中立評級，並將目標價從51美元下調至42美元。該分析師的準確率爲66%。
Considering buying BBWI stock? Here's what analysts think:
考慮購買BBWI股票嗎？以下是分析師的看法：
Read This Next:
Read This Next:
- Wall Street's Most Accurate Analysts Weigh In On 3 Health Care Stocks With Over 5% Dividend Yields
- 華爾街最準確的分析師對3只超過5%股息收益率的醫療保健股票發表看法
譯文內容由第三人軟體翻譯。
